Skip to content Skip to footer

Research Portal of the TU Dresden

Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

A. Göbel - , Department of Internal Medicine III, German Cancer Consortium (Partner: DKTK, DKFZ), German Cancer Research Center (DKFZ) (Author)
J.D. Kuhlmann - , Department of Gynecology and Obstetrics, German Cancer Consortium (Partner: DKTK, DKFZ), National Center for Tumor Diseases Dresden, German Cancer Research Center (DKFZ) (Author)
T. Link - , Department of Gynecology and Obstetrics, German Cancer Consortium (Partner: DKTK, DKFZ), National Center for Tumor Diseases Dresden, German Cancer Research Center (DKFZ) (Author)
P. Wimberger - , Department of Gynecology and Obstetrics, German Cancer Consortium (Partner: DKTK, DKFZ), National Center for Tumor Diseases Dresden, German Cancer Research Center (DKFZ) (Author)
A.J. Browne - , Medical Faculty Carl Gustav Carus (Author)
M. Rauner - , Department of Internal Medicine III, German Cancer Consortium (Partner: DKTK, DKFZ), German Cancer Research Center (DKFZ) (Author)
L.C. Hofbauer - , Department of Internal Medicine III, University Centre for Healthy Ageing, German Cancer Consortium (Partner: DKTK, DKFZ), German Cancer Research Center (DKFZ) (Author)
T.D. Rachner - , Department of Internal Medicine III, German Cancer Consortium (Partner: DKTK, DKFZ), German Cancer Research Center (DKFZ) (Author)

Details

Original language	English
Pages (from-to)	737-743
Number of pages	7
Journal	Breast Cancer Research and Treatment
Volume	164
Issue number	3
Publication status	Published - 2017
Peer-reviewed	Yes

External IDs

Scopus	85019624505
researchoutputwizard	legacy.publication#78810
ORCID	/0000-0002-8691-8423/work/155290446

Keywords

Sustainable Development Goals

SDG 3 - Good Health and Well-being